The Ministry of Health and Family Welfare has proposed significant changes to streamline the approval process for medical device manufacturing licences, a move aimed at accelerating domestic production while maintaining regulatory standards for quality, safety and performance. According to a draft notification published in the Official
20–40 age cohort drives sustained growth India’s maternity healthcare landscape is undergoing a significant shift, with more women accessing formal, institutional care than ever before. As per data from the Ministry of Health and Family Welfare, with over 88–90% of births now occurring in institutional
India may face a significant increase in the number of cancer patients over the next decade and a half, with cases projected to rise to nearly 2 million (20 lakh) by 2040, Dr. Jitendra Singh, Minister of State in the Prime Minister’s Office, informed the
In a groundbreaking public health move, the Maldives government has officially begun implementing a ‘generational ban’ on smoking, making it one of the first countries in the world to take such a bold step toward a tobacco-free future. Under the new law, citizens born after a
Empowering skilled care across India’s growing cancer treatment infrastructure As India embarks on a landmark initiative to establish 200 Day Care Cancer Centres (DCCCs) in district hospitals by 2025‑26, the government and healthcare institutions are prioritizing comprehensive training for medical staff to ensure safe and effective
Rising Alarms Over Substandard Drugs NITI Aayog has initiated a review following alarming data from the Central Drugs Standard Control Organisation (CDSCO), which revealed that multiple micro, small, and medium enterprise (MSME) pharmaceutical firms in India are producing substandard medications, prompting calls for strengthened oversight and
Parliamentary Committee Calls for Immediate Action to Address the Crisis The All India Institute of Medical Sciences (AIIMS), India's premier healthcare and medical education institution, is currently grappling with a severe staff shortage, further exacerbated by land acquisition delays and budgetary constraints. These challenges are impacting
Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026 Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading global pharmaceutical company, has achieved a significant milestone by receiving Good Manufacturing Practices (GMP) certification from
paying increased attention to rare diseases; allocation for treatment hiked to Rs 82 crore, up from zero just three years ago Successfully meeting the challenge of SMA would provide a model for effectively tackling other rare diseases in the country Rare diseases are receiving
The First Indo-Uzbek Pharma Business Forum was successfully held in Hyderabad, Telangana, focusing on trade and investment opportunities in the pharmaceutical sector between India and Uzbekistan. This landmark event was jointly organized by the Embassy of Uzbekistan in New Delhi, the Pharmaceutical Industry Development Agency
